全文获取类型
收费全文 | 1149篇 |
免费 | 56篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 20篇 |
妇产科学 | 22篇 |
基础医学 | 72篇 |
口腔科学 | 40篇 |
临床医学 | 176篇 |
内科学 | 212篇 |
皮肤病学 | 49篇 |
神经病学 | 31篇 |
特种医学 | 100篇 |
外科学 | 181篇 |
综合类 | 88篇 |
预防医学 | 132篇 |
眼科学 | 29篇 |
药学 | 99篇 |
中国医学 | 1篇 |
肿瘤学 | 27篇 |
出版年
2021年 | 9篇 |
2020年 | 6篇 |
2018年 | 22篇 |
2017年 | 8篇 |
2016年 | 13篇 |
2015年 | 8篇 |
2014年 | 15篇 |
2013年 | 33篇 |
2012年 | 44篇 |
2011年 | 29篇 |
2010年 | 46篇 |
2009年 | 40篇 |
2008年 | 33篇 |
2007年 | 77篇 |
2006年 | 52篇 |
2005年 | 37篇 |
2004年 | 49篇 |
2003年 | 48篇 |
2002年 | 53篇 |
2001年 | 40篇 |
2000年 | 55篇 |
1999年 | 31篇 |
1998年 | 38篇 |
1997年 | 29篇 |
1996年 | 36篇 |
1995年 | 23篇 |
1994年 | 15篇 |
1993年 | 26篇 |
1992年 | 17篇 |
1991年 | 28篇 |
1990年 | 14篇 |
1989年 | 25篇 |
1988年 | 13篇 |
1987年 | 20篇 |
1986年 | 13篇 |
1985年 | 24篇 |
1984年 | 9篇 |
1983年 | 14篇 |
1982年 | 16篇 |
1981年 | 14篇 |
1980年 | 10篇 |
1979年 | 18篇 |
1978年 | 18篇 |
1977年 | 14篇 |
1976年 | 10篇 |
1975年 | 8篇 |
1972年 | 5篇 |
1971年 | 6篇 |
1970年 | 5篇 |
1966年 | 5篇 |
排序方式: 共有1280条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Background: The fabrication of dental prosthesis requires the transfer of interocclusal records from patient's mouth to semiadjustable articulators using different kinds of recording media. Any inaccuracy in these interocclusal records leads to occlusal errors in the final prosthesis. This study was conducted to evaluate the dimensional changes occurring in the interocclusal recording material over a given period of time and the material's resistance to compression during the cast mounting on the articulator. 相似文献
5.
6.
Stent placement for benign pancreatic diseases: correlation between ERCP findings and clinical response. 总被引:1,自引:0,他引:1
D J Gulliver S Edmunds M E Baker S Paine J Baillie P B Cotton R P Rice 《AJR. American journal of roentgenology》1992,159(4):751-755
OBJECTIVE. We performed a study to determine if the appearance of the pancreatic duct on ERCP before and after placement of pancreatic duct stents correlates with the therapeutic response in patients treated for impaired pancreatic drainage. MATERIALS AND METHODS. Findings in 29 consecutive patients with a variety of benign pancreatic diseases in whom pancreatic stents were placed and subsequently removed within a 3-year period were reviewed retrospectively. Early (1-5 days) and late (1-3 months) clinical outcomes after stent placement were assessed. These findings were correlated with a blinded interpretation of ERCP findings (Cambridge criteria were used) before and after stent placement. RESULTS. ERCP findings before stent placement were normal in 10 patients. At the end of stent therapy, ERCP showed changes associated with chronic pancreatitis in all 10; five had focal narrowing at the tip of the stent. Subsequent ERCP studies in five of these 10 patients showed that ductal changes induced by stents diminished after stent removal. Of the 19 patients with abnormal findings on ERCP at the time of stent placement, ERCP at the end of stent therapy showed some improvement in seven patients, no change in eight, and deterioration in four. Changes seen on ERCP had no statistically significant correlation with clinical outcome (p = .36). CONCLUSION. Our findings show that pancreatic duct stents can induce abnormalities on ERCP indicative of chronic pancreatitis. However, diminution of these abnormalities after stent removal in some patients suggests that these changes may be due to edema rather than to fibrosis. Ductal changes seen on ERCP are not a useful guide for determining the degree of response to pancreatic stents. 相似文献
7.
Thrombotic and bleeding complications of prosthetic heart valves 总被引:8,自引:0,他引:8
L H Edmunds 《The Annals of thoracic surgery》1987,44(4):430-445
A review of articles published since 1979 indicates that thrombotic and bleeding complications account for about 50% of valve-related complications in patients with bioprosthetic aortic and mitral valves and for approximately 75% of the complications in patients with mechanical valves. Although compromised by lack of standard definitions and by variability in reporting and follow-up, the data suggest that the linearized rate of both thrombotic and bleeding complications in patients with aortic bioprostheses is approximately half that for aortic mechanical prostheses (2% versus 4%), but is approximately equal for both bioprostheses and mechanical valves in the mitral position (approximately 4%), and for mechanical and bioprosthetic aortic and mitral valves in combination. However, linearized rates for fatal thrombotic and bleeding events are two to four times higher in patients with mechanical prostheses. The adequacy of warfarin anticoagulation is the most important factor affecting thrombotic and bleeding complications in patients with mechanical valves and over shadows the dubious importance of other phenomena such as atrial fibrillation and left atrial thrombus. Short-term warfarin anticoagulation or the use of long-term platelet inhibitors, or both, do not appear to reduce the incidence of thrombotic complications in patients with aortic bioprostheses but increase bleeding. For mitral bioprostheses, the postoperative use of warfarin for three months or aspirin indefinitely is as effective in preventing thromboembolism as long-term warfarin. Acute prosthetic valve endocarditis is associated with a 13 to 40% incidence of thrombotic complications. Likewise, the recurrence rate of cerebral emboli is high (20-30%) in patients with prosthetic valves who are not anticoagulated. Bioprostheses are strongly preferred for women who wish to bear children; fetal wastage occurs in 25 to 30% of pregnant women with mechanical heart valves who receive either warfarin or heparin, or a combination of the two. Heparin, however, greatly increases the risk of maternal bleeding. In children, the efficacy of platelet inhibitors without warfarin anticoagulation is unproven; nearly all serious strokes occur when warfarin is omitted; and permanent disability from warfarin-related bleeding is rare. All prosthetic cardiac valves initiate coagulation and affect the dynamic equilibrium between activated procoagulants and endogenous anticoagulants. Warfarin is the only available oral exogenous anticoagulant.(ABSTRACT TRUNCATED AT 400 WORDS) 相似文献
8.
Fusion of the metarcarpophalangeal joint of the thumb is an accepted treatment in the management of instability or osteoarthritis following trauma to this joint. A review was made of the literature and 30 of the senior author's (RH) patients who had had this operation, in order to determine what effect the operation had on the pain in their thumb, any symptoms of instability, interference with work and daily activities, and strength in the hand. All of the patients achieved bony union and the average angle of fusion was 7.6 degrees of flexion. All of the patients were either satisfied or very satisfied with the results of the operation, and had an average increase of 6.3 points on a 12 point rating scale. However, 48% of patients had some mild intermittent pain and 43% complained of some difficulty with fine motor tasks. Twelve patients were able to attend for formal evaluation including the Jebson and Crawford Hand Function Tests which revealed some decrease in hand function in all of those tested. It was concluded that this method of arthrodesis of the metacarpophalangeal joint of the thumb gives reliable results, with high patient acceptance, but does not result in an entirely normal thumb or hand function. 相似文献
9.
10.
Hepatic failure associated with imipramine therapy 总被引:1,自引:0,他引:1
Imipramine, a widely used antidepressant, has rarely been associated with hepatic abnormalities. In the majority of reported cases, hepatic effects have been transient and readily reversible on discontinuation of the drug. We cared for an 11-year-old boy with hepatic failure and massive cell necrosis which followed treatment with imipramine for enuresis. This therapy led to fulminant hepatic failure and subsequent liver transplantation. 相似文献